Related Experiment Videos
Fluconazole-induced agranulocytosis with eosinophilia
1College of Pharmacy, Western University of Health Sciences, Pomona, California 91766-1889, USA.
Pharmacotherapy
|April 20, 2000
Abstract:
Fluconazole is a commonly prescribed antifungal agent with a favorable safety profile. A patient experienced agranulocytosis and eosinophilia associated with the drug. Similar bone marrow-suppressive effect due to the azoles is rarely described in the English-language literature.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antimicrobial Stewardship Opportunities in Patients with Bacteremia Not Identified by BioFire FilmArray.
Journal of clinical microbiology·2019
Emergency Department Urinary Antibiograms Differ by Specific Patient Group.
Journal of clinical microbiology·2017
Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2008
Implementing a program for switching from i.v. to oral antimicrobial therapy.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
Lipid formulations of amphotericin B: clinical efficacy and toxicities.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1998
Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.
Pharmacotherapy·2026
Cluster of imported cutaneous leishmaniasis due to Leishmania major among travellers returning from central Tunisia, France, October 2025 to May 2026.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Early metastatic BRAFV600E mutation melanoma without known primary lesion: a case report.
Annals of medicine and surgery (2012)·2026